Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04261088 · ClinicalTrials.gov registry record
Assisted Suicide in Switzerland
A clinical trial of Assisted Suicide, sponsored by National Institutes of Health Clinical Center (CC).
- Active
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT04261088: Active study of Assisted Suicide, sponsored by National Institutes of Health Clinical Center (CC).
NCT04261088 is a study of Assisted Suicide that is active but no longer recruiting, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 25 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04261088, a study of Assisted Suicide, is active but no longer recruiting, sponsored by National Institutes of Health Clinical Center (CC).
- ACTIVE NOT RECRUITING
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: Researchers want to learn more about how the Swiss model of assisted suicide works. To do this, they have interviewed 25 Swiss experts. The researchers will draw on research in the fields of ethics, law, and medicine to analyze the transcripts. Objective: To describe the practice of assisted suicide in Switzerland and to study how the policy is carried out, how the right-to-die societies work, and the ethical implications of the practice. Eligibility: Swiss experts in the field of assisted suicide Design: The study includes 25 interviews that have already been conducted. The participants were: * academics * doctors and others in medical care * a government official * representatives of right-to-die societies. Researchers will analyze the data using qualitative methods. Two researchers will develop a coding scheme and code the texts and analyze the data.
Primary Outcome
This is a qualitative descriptive study of transcripts.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2020-02-03 |
| Est. Completion | 2027-01-31 |
What the registry record for NCT04261088 still lists
NCT04261088 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 1 condition, with Assisted Suicide appearing as the primary indexed condition, and to 0 interventions.
NCT04261088 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT04261088 about?
NCT04261088 is a clinical study titled "Assisted Suicide in Switzerland". Background: Researchers want to learn more about how the Swiss model of assisted suicide works. To do this, they have interviewed 25 Swiss experts. The researchers will draw on research in the fields of ethics, law, and medicine to analyze the transcripts. Objective: To describe the practice of a...
What is the current status of trial NCT04261088?
This trial is currently active not recruiting. The enrollment target is 25 participants. The study started on 2020-02-03. Estimated completion is 2027-01-31.
What conditions does trial NCT04261088 study?
This clinical trial studies the following conditions: Assisted Suicide.
Who is sponsoring clinical trial NCT04261088?
This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04261088 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI